Needham Reiterates Buy on Absci, Maintains $11 Price Target

9/23/2026
Impact: 75
Healthcare

Needham analyst Gil Blum has reiterated a Buy rating on Absci (NASDAQ: ABSI) and has maintained a price target of $11 for the stock.

AI summary, not financial advice

Share: